OTCMKTS:CVALF Covalon Technologies (CVALF) Stock Price, News & Analysis $1.55 0.00 (0.00%) (As of 04:13 PM ET) Add Compare Share Share Today's Range$1.55▼$1.5550-Day Range$0.74▼$1.7352-Week Range$0.73▼$1.73Volume4,100 shsAverage Volume6,952 shsMarket Capitalization$38.86 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsHeadlinesShort InterestStock AnalysisChartEarningsHeadlinesShort Interest Get Covalon Technologies alerts: Email Address Ad StockEarningsRe: We’re giving you all this for less than a pair of socksThe Only Trading Tool You'll Need This Year Forget juggling multiple subscriptions and confusing indicators... Our all-in-one Premium Membership gives you everything you need to potentially profit in any market. Members have seen gains of 76.2%, 85.6%, and even 111.3% on single trades. This July 4th, get 12 months of access for just $4. Don't let this unprecedented offer slip away. About Covalon Technologies Stock (OTCMKTS:CVALF)Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company's platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity. It also offers medical coating platform, a process that utilizes photo-polymerization to create active grafting sites where new polymer chains are initiated and propagated from the surface of an existing medical device. In addition, the company provides wound care dressings; surgical and peri-operative; and infection management products. It offers its products under the Covalon brand name through third-party distribution networks and company's direct sales force. The company serves hospitals, wound care centers, burn centers, extended/alternate care and acute care facilities, home health care agencies, and physicians' offices. Covalon Technologies Ltd. is headquartered in Mississauga, Canada.Read More CVALF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CVALF Stock News HeadlinesMay 29, 2024 | businesswire.comCovalon Announces Profitable Second Quarter Fiscal 2024 ResultsMay 22, 2024 | businesswire.comCovalon Announces Conference Call to Discuss Second Quarter Fiscal 2024 Financial ResultsJuly 2, 2024 | Behind the Markets (Ad)URGENT: Another Country Abandons the DollarVietnam just ditched the US dollar. And they're not alone. BRICS nations are rapidly moving away from the greenback, threatening the stability of your retirement savings. Your wealth could vanish overnight.May 17, 2024 | businesswire.comCovalon Presents Compassionate Care Technology at the Infusion Nurses Society (INS) Annual Meeting & Exhibition in Kansas City, MOMarch 7, 2024 | finance.yahoo.comCovalon Announces Voting Results from Fiscal 2023 Annual Meeting of ShareholdersFebruary 28, 2024 | businesswire.comCovalon To Hold Annual Meeting of Shareholders on Wednesday, March 6, 2024February 28, 2024 | businesswire.comCovalon Announces First Quarter Fiscal 2024 ResultsJanuary 28, 2024 | finance.yahoo.comCovalon Technologies Full Year 2023 Earnings: CA$0.18 loss per share (vs CA$0.36 loss in FY 2022)July 2, 2024 | Behind the Markets (Ad)URGENT: Another Country Abandons the DollarVietnam just ditched the US dollar. And they're not alone. BRICS nations are rapidly moving away from the greenback, threatening the stability of your retirement savings. Your wealth could vanish overnight.November 15, 2023 | finance.yahoo.comCovalon’s VALGuard Gains Prestigious Recognition in the British Journal of NursingOctober 25, 2023 | theglobeandmail.comClosing Bell: Covalon Technologies Ltd down on Thursday (COV)September 26, 2023 | finance.yahoo.comCovalon Announces Leadership ChangesSeptember 25, 2023 | benzinga.comLife with a Central Line [WEBINAR]: Key Considerations from the Patient's PerspectiveSeptember 19, 2023 | finance.yahoo.comCovalon Showcases Compassionate Pediatric Care Solutions at 47th APHON ConferenceAugust 16, 2023 | finance.yahoo.comCovalon Announces Third Quarter Fiscal 2023 ResultsAugust 14, 2023 | finance.yahoo.comCovalon Announces Conference Call to Discuss Third Quarter Fiscal 2023 Financial ResultsJune 26, 2023 | finance.yahoo.comCovalon Announces Participation in APIC Annual Conference & Exposition on June 26 – 28, 2023 in Orlando, FloridaJune 13, 2023 | finance.yahoo.comBreakthrough Solution for Fragile Skin: Covalon’s IV Clear® Dressing Recommended by Physicians at a Top 10 U.S. Children’s Hospital and Epidermolysis Bullosa Center of ExcellenceMay 16, 2023 | finance.yahoo.comCovalon, Leader in Compassionate Pediatric Infection Prevention Solutions, to Participate in Neonatal/Fetal Conference in Columbus, Ohio on May 17 - 19, 2023May 9, 2023 | theglobeandmail.comClosing Bell: Covalon Technologies Ltd up on Friday (COV)April 26, 2023 | finance.yahoo.comCompassionate Care Solutions Provider Covalon Participating in the Canadian Vascular Access Association and World Congress on Vascular Access Joint Conference on April 26-28, 2023 in TorontoApril 20, 2023 | finance.yahoo.comCovalon to Present at the Planet MicroCap Showcase: VEGAS 2023 on Wednesday, April 26, 2023 & Hold 1x1 Meetings on Thursday, April 27, 2023March 20, 2023 | finance.yahoo.comLeader in Compassionate Care Infection Prevention Solutions, Covalon, to Participate in the Synova NICU Leadership Forum 2023 in Tucson, Arizona from March 19 to 23, 2023February 28, 2023 | finance.yahoo.comCovalon To Hold Annual and Special Meeting of Shareholders on Wednesday, March 8, 2023February 23, 2023 | finance.yahoo.comCovalon Announces Improved First Quarter Fiscal 2023 ResultsFebruary 20, 2023 | finance.yahoo.comInfection Prevention Solutions Provider Covalon to Participate for the First Time in NEO - The Conference for Neonatology in Las Vegas, NV on February 22-24, 2023January 26, 2023 | msn.comCovalon Technologies GAAP EPS of -$0.16, revenue of $5.39MSee More Headlines Receive CVALF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Covalon Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/29/2024Today7/02/2024Fiscal Year End9/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Health services Sub-IndustryN/A Current SymbolOTCMKTS:CVALF CUSIPN/A CIKN/A Webwww.covalon.com Phone(905) 568-8400FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.09) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-3,310,000.00 Net Margins-10.61% Pretax Margin-10.55% Return on Equity-14.41% Return on Assets-11.50% Debt Debt-to-Equity RatioN/A Current Ratio6.80 Quick Ratio4.85 Sales & Book Value Annual Sales$19.72 million Price / Sales1.97 Cash FlowN/A Price / Cash FlowN/A Book Value$0.56 per share Price / Book2.77Miscellaneous Outstanding Shares25,068,000Free FloatN/AMarket Cap$38.86 million OptionableNot Optionable Beta-0.32 Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.Get This Free Report Key ExecutivesMr. Ronald HebertSenior Vice President of GrowthMr. Amir Boloor CFAExecutive ChairmanMr. Brent AshtonCEO & DirectorDr. Valerio DiTizio (Age 56)Co-Founder, Chief Scientific Officer & VP Comp: $128.97kMs. Katie MartinovichInterim Chief Financial OfficerMs. Kim CrooksSenior Vice President of OperationsMr. Greg LeszczynskiVice President of Human ResourcesGerry ArambulaPresident of Covalon Technologies AG Ltd.Mr. Hamed AbbasianVice President of Business DevelopmentEmily HillExecutive Assistant to the CEOMore ExecutivesKey CompetitorsEUDA HealthNASDAQ:EUDAAgape ATPNASDAQ:ATPCXcelerateOTCMKTS:XCRTUpHealthNYSE:UPHLUnion DentalOTCMKTS:UDHIView All Competitors CVALF Stock Analysis - Frequently Asked Questions How have CVALF shares performed in 2024? Covalon Technologies' stock was trading at $0.77 at the start of the year. Since then, CVALF stock has increased by 101.3% and is now trading at $1.55. View the best growth stocks for 2024 here. Are investors shorting Covalon Technologies? Covalon Technologies saw a decline in short interest during the month of June. As of June 15th, there was short interest totaling 1,000 shares, a decline of 86.3% from the May 31st total of 7,300 shares. Based on an average trading volume of 3,500 shares, the days-to-cover ratio is currently 0.3 days. View Covalon Technologies' Short Interest. How were Covalon Technologies' earnings last quarter? Covalon Technologies Ltd. (OTCMKTS:CVALF) released its quarterly earnings results on Wednesday, May, 29th. The company reported $0.04 EPS for the quarter. The company earned $6.22 million during the quarter. Covalon Technologies had a negative trailing twelve-month return on equity of 14.41% and a negative net margin of 10.61%. How do I buy shares of Covalon Technologies? Shares of CVALF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:CVALF) was last updated on 7/2/2024 by MarketBeat.com Staff From Our PartnersOperation Replace Biden is a GoLast night’s debate proved me right: Joe Biden will be replaced. I’ve been making this warning for months… ...The Freeport Society | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredRe: We’re giving you all this for less than a pair of socksThe Only Trading Tool You'll Need This Year Forget juggling multiple subscriptions and confusing indicator...StockEarnings | Sponsored1k a day while computer does all work?What I discovered is now helping me take in more than 1k a day. It's like a "magic key" to passive income ...Digital Mavericks Media | Sponsored270x more lucrative than NVIDIA???If you've missed out on NVIDIA's recent 1,600% run... Don't worry. Because there's one AI stock that cou...Behind the Markets | SponsoredWho are Nvidia’s New Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredWill Biden Be Replaced?There are growing rumors of a possible Joe Biden replacement following his first debate against Donald Trump. ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Covalon Technologies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Covalon Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.